Teleflex (NYSE:TFX) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Teleflex (NYSE:TFX) from a buy rating to a strong-buy rating in a research note released on Sunday.

Several other equities analysts have also recently commented on the company. Wells Fargo & Company reduced their target price on Teleflex from $137.00 to $131.00 and set an “equal weight” rating for the company in a research report on Friday, August 1st. Mizuho boosted their target price on Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research report on Friday, August 1st. Finally, Royal Bank Of Canada boosted their target price on Teleflex from $130.00 to $135.00 and gave the stock a “sector perform” rating in a research report on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $141.57.

Teleflex Price Performance

Shares of NYSE TFX opened at $130.30 on Friday. The stock has a market cap of $5.76 billion, a PE ratio of 30.66, a price-to-earnings-growth ratio of 1.82 and a beta of 1.08. Teleflex has a fifty-two week low of $108.90 and a fifty-two week high of $249.90. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The stock has a fifty day moving average of $120.33 and a 200-day moving average of $127.05.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, beating the consensus estimate of $3.36 by $0.37. The company had revenue of $780.90 million during the quarter, compared to analysts’ expectations of $771.53 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The firm’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the business earned $3.42 earnings per share. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. Equities research analysts anticipate that Teleflex will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, August 15th. Teleflex’s payout ratio is currently 32.00%.

Insiders Place Their Bets

In other Teleflex news, Director Gretchen R. Haggerty purchased 500 shares of the business’s stock in a transaction that occurred on Wednesday, August 6th. The stock was acquired at an average cost of $114.75 per share, with a total value of $57,375.00. Following the completion of the acquisition, the director directly owned 6,305 shares of the company’s stock, valued at $723,498.75. This represents a 8.61% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Andrew A. Krakauer purchased 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 5th. The stock was acquired at an average cost of $115.25 per share, with a total value of $115,250.00. Following the completion of the acquisition, the director directly owned 7,192 shares of the company’s stock, valued at $828,878. The trade was a 16.15% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 5,500 shares of company stock valued at $633,590 over the last three months. Company insiders own 1.40% of the company’s stock.

Institutional Trading of Teleflex

Several institutional investors and hedge funds have recently added to or reduced their stakes in TFX. Norges Bank bought a new stake in Teleflex during the 2nd quarter worth about $65,826,000. Pzena Investment Management LLC bought a new stake in Teleflex during the 2nd quarter worth about $42,149,000. Dimensional Fund Advisors LP raised its holdings in Teleflex by 69.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company’s stock worth $119,927,000 after purchasing an additional 355,720 shares during the last quarter. Diamond Hill Capital Management Inc. raised its holdings in Teleflex by 122.8% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company’s stock worth $80,784,000 after purchasing an additional 322,222 shares during the last quarter. Finally, Invenomic Capital Management LP raised its holdings in Teleflex by 1,400.1% during the 1st quarter. Invenomic Capital Management LP now owns 344,732 shares of the medical technology company’s stock worth $47,639,000 after purchasing an additional 321,751 shares during the last quarter. 95.62% of the stock is owned by institutional investors.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.